MEDP Medpace Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MEDP

Price (delayed)

$601.38

Market cap

$16.79B

P/E Ratio

34.62

Dividend/share

N/A

EPS

$17.37

Enterprise value

$16.4B

?
Relative Growth: Rel. Growth: 97
Relative Strength: Rel. Strength: 78
Relative Valuation: Rel. Valuation: 36
Relative Profitability: Rel. Profitability: 51

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate ...

Highlights
The EPS is up by 26% YoY and by 7% QoQ
MEDP's revenue is up by 25% year-on-year and by 3.9% since the previous quarter
Medpace Holdings's equity has soared by 152% YoY but it has decreased by 27% from the previous quarter
Medpace Holdings's quick ratio has surged by 89% YoY but it has decreased by 15% QoQ
The P/E is 15% higher than the 5-year quarterly average of 30.2 and 6% higher than the last 4 quarters average of 32.8
Medpace Holdings's gross margin has decreased by 9% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.medpace.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of MEDP

MEDP stock price

How has the Medpace Holdings stock price performed over time
Intraday
-0.73%
1 week
11.84%
1 month
17.28%
1 year
31.97%
YTD
7.07%
QTD
13.56%

Financial performance

How have Medpace Holdings's revenue and profit performed over time
Revenue
$2.78B
Gross profit
$800.22M
Operating income
$583.4M
Net income
$491.5M
Gross margin
28.8%
Net margin
17.7%
MEDP's revenue is up by 25% year-on-year and by 3.9% since the previous quarter
The operating income has increased by 22% year-on-year and by 3.6% since the previous quarter
The net income has increased by 17% YoY and by 7% from the previous quarter
MEDP's gross profit is up by 13% year-on-year and by 2.8% since the previous quarter

Price vs fundamentals

How does MEDP's price correlate with its fundamentals

Growth

What is Medpace Holdings's growth rate over time

Valuation

What is Medpace Holdings stock price valuation
MEDP P/E details
P/E
34.62
P/B
39.59
P/S
6.09
EV/EBIT
27.98
EV/EBITDA
25.74
EV/Sales
5.9
The EPS is up by 26% YoY and by 7% QoQ
The P/E is 15% higher than the 5-year quarterly average of 30.2 and 6% higher than the last 4 quarters average of 32.8
Medpace Holdings's equity has soared by 152% YoY but it has decreased by 27% from the previous quarter
MEDP's price to book (P/B) is 93% higher than its 5-year quarterly average of 20.5 and 12% higher than its last 4 quarters average of 35.3
MEDP's revenue is up by 25% year-on-year and by 3.9% since the previous quarter
MEDP's price to sales (P/S) is 22% more than its 5-year quarterly average of 5.0 and 7% more than its last 4 quarters average of 5.7

Efficiency

How efficient is Medpace Holdings business performance
The company's return on equity has surged by 63% YoY but it fell by 9% QoQ
Medpace Holdings's return on assets has increased by 13% YoY

Dividends

What is MEDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MEDP.

Financial health

How did Medpace Holdings financials performed over time
The company's total assets is 27% higher than its total liabilities
Medpace Holdings's quick ratio has surged by 89% YoY but it has decreased by 15% QoQ
Medpace Holdings's current ratio has surged by 70% YoY but it has decreased by 14% QoQ
The debt is 72% smaller than the equity
Medpace Holdings's equity has soared by 152% YoY but it has decreased by 27% from the previous quarter
MEDP's debt to equity has dropped by 61% year-on-year but it is up by 40% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.